Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Xiaotansanjiefang** is a traditional Chinese medicine (TCM) multi-herbal formula historically used for the treatment of gastrointestinal cancers such as colorectal and gastric cancer. It consists of Ban-xia, Nan-xing, Fu-ling, Zhi-shi, Chen-pi, Quan-xie, Wu-gong, Ji-nei-jin, Bei-mu, Bai-jie-zi, and Gan-cao in specific proportions. In vitro and animal studies suggest Xiaotansanjiefang suppresses the proliferation and migration of colorectal cancer cells, promotes apoptosis, and inhibits tumor growth and angiogenesis. Mechanistic studies indicate that its anti-cancer effects are closely associated with downregulation of the Jagged 1/Notch 3/Snail signaling pathway, as well as additional modulation of targets and pathways like TP53, MAPK1/3, STAT3, PI3K-Akt, and TNF signaling[1][2]. Its major active small-molecule components include quercetin, β-sitosterol, naringenin, nobiletin, kaempferol, and luteolin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaotansanjiefang.